Citadel Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,157,166
| Closed | -$14.4M | – | 6891 |
|
|
2023
Q3 | $14.4M | Sell |
2,157,166
-297,807
| -12% | -$1.99M | ﹤0.01% | 951 |
|
|
2023
Q2 | $22.2M | Sell |
2,454,973
-733,055
| -23% | -$6.64M | ﹤0.01% | 759 |
|
|
2023
Q1 | $23.2M | Sell |
3,188,028
-63,552
| -2% | -$462K | 0.01% | 782 |
|
|
2022
Q4 | $23.7M | Sell |
3,251,580
-428,417
| -12% | -$3.12M | 0.01% | 780 |
|
|
2022
Q3 | $28.4M | Buy |
3,679,997
+1,369,820
| +59% | +$10.6M | 0.01% | 634 |
|
|
2022
Q2 | $15.7M | Sell |
2,310,177
-182,986
| -7% | -$1.25M | ﹤0.01% | 973 |
|
|
2022
Q1 | $19.9M | Buy |
2,493,163
+37,359
| +2% | +$298K | ﹤0.01% | 917 |
|
|
2021
Q4 | $13.8M | Buy |
2,455,804
+9,439
| +0.4% | +$52.9K | ﹤0.01% | 1198 |
|
|
2021
Q3 | $18.8M | Buy |
2,446,365
+1,946,365
| +389% | +$15M | ﹤0.01% | 953 |
|
|
2021
Q2 | $4.81M | Sell |
500,000
-8,819
| -2% | -$84.8K | ﹤0.01% | 2204 |
|
|
2021
Q1 | $5.35M | Buy |
508,819
+8,660
| +2% | +$91K | ﹤0.01% | 2017 |
|
|
2020
Q4 | $6.98M | Sell |
500,159
-655
| -0.1% | -$9.14K | ﹤0.01% | 1494 |
|
|
2020
Q3 | $7.2M | Buy |
+500,814
| New | +$7.2M | ﹤0.01% | 1282 |
|